HCG Appoints Sanjeev Kumar as CFO, Re-appoints Director

1 min read     Updated on 21 May 2026, 07:34 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

HealthCare Global Enterprises Limited announced key leadership appointments and re-appointments following its Board meeting on May 19, 2026. Sanjeev Kumar was appointed Chief Financial Officer effective May 25, 2026, replacing Interim CFO Dr. Manish Mattoo. The Board re-appointed Rajiv Maliwal as Non-Executive Independent Director for five years, subject to shareholder approval, and Vijay S. Shanbhag as Internal Auditor for one year. Additionally, Ravi Gothwal was appointed as AVP – Investor Relations.

powered bylight_fuzz_icon
40762799

*this image is generated using AI for illustrative purposes only.

HealthCare Global Enterprises Limited has announced a series of key appointments and re-appointments following its Board meeting held on May 19, 2026. The decisions, taken under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, include changes to the Board of Directors, the Chief Financial Officer, and senior management personnel.

Board and Senior Management Changes

The Board approved the re-appointment of Mr. Rajiv Maliwal as a Non-Executive Independent Director for a second term of five consecutive years, effective from May 25, 2026. This re-appointment is subject to the approval of the company's shareholders. Mr. Maliwal shall not be liable to retire by rotation.

In a significant shift in the finance leadership, Mr. Sanjeev Kumar has been appointed as the Chief Financial Officer and Key Managerial Personnel of the company. His appointment is effective from the commencement of business hours on May 25, 2026. Consequently, Dr. Manish Mattoo, who was serving as the Interim Chief Financial Officer, shall cease to hold this position effective from the same date.

New Investor Relations Head

The company has strengthened its investor relations function with the appointment of Mr. Ravi Gothwal as AVP – Investor Relations. He has been designated as a Senior Management Personnel, with his appointment effective immediately from May 19, 2026.

Internal Auditor Re-appointment

The Board also approved the re-appointment of Mr. Vijay S. Shanbhag as the Internal Auditor of the company for a further term of one year. This appointment under Section 138 of the Companies Act, 2013, is effective from May 30, 2026.

Summary of Appointments

Name Designation Effective Date Term
Mr. Rajiv Maliwal Non-Executive Independent Director May 25, 2026 5 years
Mr. Sanjeev Kumar Chief Financial Officer May 25, 2026 As per terms of employment
Mr. Ravi Gothwal AVP – Investor Relations May 19, 2026 As per terms of employment
Mr. Vijay S. Shanbhag Internal Auditor May 30, 2026 1 year

How might Mr. Sanjeev Kumar's financial leadership style and background influence HealthCare Global Enterprises' capital allocation strategy and upcoming fundraising plans?

Will the strengthened investor relations function under Mr. Ravi Gothwal signal a push for increased institutional investor engagement or a potential secondary offering in the near term?

Could the shareholder vote on Mr. Rajiv Maliwal's re-appointment as Independent Director face any opposition given evolving corporate governance scrutiny in the Indian healthcare sector?

HCG releases Q4FY26 earnings call audio recording

0 min read     Updated on 21 May 2026, 04:01 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

HealthCare Global Enterprises announced the availability of the audio recording for its earnings call held on May 20, 2026. The call discussed the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The disclosure complies with Regulation 30 of SEBI LODR Regulations, 2015.

powered bylight_fuzz_icon
40836317

*this image is generated using AI for illustrative purposes only.

healthcare global enterprises has announced that the audio recording of its earnings call held with analysts and investors is now available. The call took place on May 20, 2026, to discuss the audited financial results for the quarter and year ended March 31, 2026.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had previously intimated the exchanges regarding the conduct of this earnings call.

The recording covers the standalone and consolidated financial performance of the company for the specified period. Investors and interested parties can access the audio file through the investor relations section of the company's website.

The link provided by the company for accessing the recording is https://www.hcgoncology.com/investor-relations/ . The intimation was signed by Sunu Manuel, Company Secretary & Compliance Officer.

Key Details

Detail Information
Event Earnings Call Audio Recording Availability
Date of Call May 20, 2026
Period Covered Quarter and Year ended March 31, 2026
Regulation Regulation 30 of SEBI LODR Regulations, 2015

How did HCG Healthcare Global Enterprises' revenue and EBITDA margins for FY2026 compare to its oncology sector peers, and what does this signal for its competitive positioning going forward?

What strategic expansion plans or capital allocation priorities did HCG's management outline for FY2027, particularly regarding new cancer care centers or technology investments?

Given the growing demand for oncology services in India, how is HCG positioned to capitalize on potential consolidation opportunities in the healthcare sector over the next 12-24 months?

More News on Healthcare Global Enterprises